Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serpin family A member 3 | 0.486 | 0.846 | 8.8E-14 |
|
disease | 0.070 | None | 0.714 | 1 | 0 | 1997 | 2018 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.060 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 2006 | 2017 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1998 | 2010 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
sequestosome 1 | 0.428 | 0.885 | 8.6E-04 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2009 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
saitohin | 0.705 | 0.385 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2010 | |||||||||
|
WW and C2 domain containing 1 | 0.610 | 0.692 | 3.9E-04 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2009 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2003 | 2008 | ||||||||
|
solute carrier family 1 member 3 | 0.573 | 0.577 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
microRNA 659 | 0.805 | 0.192 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2011 | |||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2001 | 2008 | ||||||||
|
solute carrier family 17 member 7 | 0.636 | 0.308 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2001 | 2002 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2003 | 2011 |